Author: [AUTHOR] Published on 7/1/2020 12:00:00 AM
Sara Belli, PhD, Clinical Pharmacologist, Roche Innovation Center, Basel, Switzerland
Dr. Alex Phipps, Dr. Belli’s Clinical Pharmacology Group Head, introduced her to ASCPT. He encouraged her to join the Society and to participate in the Annual Meeting. She looks forward to valuable discussions, new ideas, different views, and creative thinking from peer colleagues with multidisciplinary backgrounds ranging from academia, industry, and regulatory institutions. She believes her membership in ASCPT will help her connect with outstanding researchers in the field coming from the whole world. She looks forward to enriching her education and experience in clinical pharmacology through these interactions.
Dr. Belli is particularly interested in the quickly evolving fields of clinical pharmacology, such as primary health care and new model‐informed drug development strategies. Dr. Belli is working in clinical trial design with a focus in animal‐to‐human translations, first‐in‐human dose selection, safety, PK/PD, and dose escalation strategies for oncology patients. She is currently working as a Clinical Pharmacologist at F. Hoffman‐La Roche AG Basel and Zurich in various cancer immunotherapy and oncology nuclear medicine projects.